Ginkgo Bioworks Holdings (DNA) Net Income (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has reported Net Income for 7 consecutive years, with -$46.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Income rose 22.54% year-over-year to -$46.7 million; the trailing twelve-month figure through Jun 2026 stood at -$290.8 million (up 7.74% YoY), and the FY2025 full-year result was -$312.8 million, up 42.83% from the prior year.
• Net Income improved to -$46.7 million in Q2 2026 per DNA's latest filing, from -$82.6 million in the prior quarter.
• Across five years, Net Income topped out at -$46.7 million in Q2 2026 and bottomed at -$670.6 million in Q2 2022.
• Historically, Net Income has averaged -$221.6 million across 5 years, with a median of -$169.5 million in 2022.
• The widest YoY moves for Net Income: up 89.22% in 2022, down 1131.22% in 2022.
• Over 5 years, Net Income stood at -$173.1 million in 2022, then decreased by 22.31% to -$211.7 million in 2023, then jumped by 49.2% to -$107.5 million in 2024, then climbed by 24.91% to -$80.8 million in 2025, then soared by 42.16% to -$46.7 million in 2026.
• According to Business Quant data, Net Income over the past three periods registered -$46.7 million, -$82.6 million, and -$80.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.